MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Accuray Inc

Затворен

СекторЗдравеопазване

1.34

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.29

Максимум

1.34

Ключови измерители

By Trading Economics

Приходи

-3.8M

-1.3M

Продажби

-2.9M

113M

Марж на печалбата

-1.145

Служители

987

EBITDA

-6.6M

1M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+304.51% upside

Дивиденти

By Dow Jones

Следващи печалби

13.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-25M

140M

Предишно отваряне

1.34

Предишно затваряне

1.34

Настроения в новините

By Acuity

19%

81%

32 / 376 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Accuray Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.07.2025 г., 23:56 ч. UTC

Придобивния, сливания и поглъщания

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- 2nd Update

16.07.2025 г., 23:43 ч. UTC

Придобивния, сливания и поглъщания

Santos 2Q Output Rises 1% as Takeover Campaign Continues

16.07.2025 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- Update

16.07.2025 г., 22:38 ч. UTC

Придобивния, сливания и поглъщания

Alimentation Couche-Tard Withdraws Seven & i Acquisition Proposal

16.07.2025 г., 23:44 ч. UTC

Пазарно говорене

Gold Steady; Geopolitical Tensions in Middle East Support -- Market Talk

16.07.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Fall as Yen Strengthens -- Market Talk

16.07.2025 г., 23:24 ч. UTC

Пазарно говорене

Australian Job Market Data to Shape RBA Calls -- Market Talk

16.07.2025 г., 23:18 ч. UTC

Придобивния, сливания и поглъщания

Santos Now Expects 2025 Production of 90 Million-95 Million BOE

16.07.2025 г., 23:18 ч. UTC

Придобивния, сливания и поглъщания

Santos Cuts Top End of 2025 Production Guidance

16.07.2025 г., 23:17 ч. UTC

Придобивния, сливания и поглъщания

Santos: Production Recovery Underway in Cooper Basin

16.07.2025 г., 23:17 ч. UTC

Придобивния, сливания и поглъщания

Santos: Over 200 Wells, Several Upstream Compressors in Cooper Basin Shut In

16.07.2025 г., 23:17 ч. UTC

Придобивния, сливания и поглъщания

Santos: Cooper Basin Production Impacted by Floods in 2Q

16.07.2025 г., 23:16 ч. UTC

Придобивния, сливания и поглъщания

Santos: Pikka Phase 1 Project in Alasia 89% Complete

16.07.2025 г., 23:16 ч. UTC

Придобивния, сливания и поглъщания

Santos Keeps 2025 Major Development Project Capex Guidance Unchanged

16.07.2025 г., 23:13 ч. UTC

Придобивния, сливания и поглъщания

Santos Had Gearing of 20.5% at End-June, Excluding Operating Leases

16.07.2025 г., 23:13 ч. UTC

Придобивния, сливания и поглъщания

Santos Says Moomba CCS Phase 1 Project Performing to Expectations

16.07.2025 г., 23:12 ч. UTC

Придобивния, сливания и поглъщания

Santos Narrows 2025 Unit Production Cost Guidance to US$7.00-US$7.40/BOE

16.07.2025 г., 23:12 ч. UTC

Придобивния, сливания и поглъщания

Santos 1H Free Cash Flow From Operations US$1.1 Billion

16.07.2025 г., 23:11 ч. UTC

Придобивния, сливания и поглъщания

Santos 2Q Free Cash Flow From Operations US$620 Million

16.07.2025 г., 23:11 ч. UTC

Придобивния, сливания и поглъщания

Santos 2Q Oil, Natural Gas Output 22.2 Million BOE

16.07.2025 г., 23:11 ч. UTC

Придобивния, сливания и поглъщания

Santos 2Q Oil, Natural Gas Sales Volumes 23.9 Million BOE

16.07.2025 г., 23:11 ч. UTC

Придобивния, сливания и поглъщания

Santos 2Q Oil, Natural Gas Sales Volumes Up 3% on 1Q

16.07.2025 г., 23:11 ч. UTC

Придобивния, сливания и поглъщания

Santos 2Q Oil, Natural Gas Output Up 1% on 1Q

16.07.2025 г., 22:43 ч. UTC

Пазарно говорене

Alcoa Using High Costs of More Production to Battle Tariff -- Market Talk

16.07.2025 г., 22:35 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

16.07.2025 г., 22:35 ч. UTC

Пазарно говорене
Печалби

Replacing Aluminum Imports With U.S. Production Not Seen Feasible -- Market Talk

16.07.2025 г., 22:33 ч. UTC

Пазарно говорене
Печалби

Alcoa Will Continue to Ship Aluminum Outside of the U.S. -- Market Talk

16.07.2025 г., 22:28 ч. UTC

Пазарно говорене
Печалби

Aluminum Price in U.S. Doesn't Offset Tariff Costs, Alcoa says -- Market Talk

16.07.2025 г., 22:22 ч. UTC

Пазарно говорене
Печалби

Market Talk Roundup: Latest on U.S. Politics

16.07.2025 г., 22:22 ч. UTC

Пазарно говорене
Печалби

Alcoa Considers Restart of Idle Capacity at Indiana Smelter -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Accuray Inc Прогноза

Ценова цел

By TipRanks

304.51% нагоре

12-месечна прогноза

Среден 5.38 USD  304.51%

Висок 7 USD

Нисък 4 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Accuray Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

4 ratings

4

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

1.28 / 1.61Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

32 / 376 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.